Video by PCR via YouTube
Go to Source

Alessandro Sticchi interviews David E. Kandzari about the 3-month primary results of the Target Bp I randomized clinical trial which he presented at #ACC24
The trial reports mixed results on nerve ablation for high blood pressure with a modest but statistically significant difference in lowered blood pressure at 3 months, but no significant differences in other measures. Unexpectedly large blood pressure reductions in the sham group merit further study. The safety profile appears favourable.

More news about the ACC.24 on PCRonline: https://www.pcronline.com/News/Whats-new-on-PCRonline/2024/ACC/PCR-ACC-Scientific-Sessions

Go to Source